JOHN C. BOLGER - 30 Aug 2021 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role
Director
Signature
/s/ Paul Kim, as Attorney-in-fact
Issuer symbol
FLGT
Transactions as of
30 Aug 2021
Net transactions value
-$77,476
Form type
4
Filing time
01 Sep 2021, 17:50:06 UTC
Previous filing
07 Jun 2021
Next filing
03 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGT Common Stock Options Exercise $1,225 +312 +16% $3.92* 2,312 30 Aug 2021 Direct
transaction FLGT Common Stock Sale $28,511 -312 -13% $91.38 2,000 30 Aug 2021 Direct
transaction FLGT Common Stock Options Exercise $4,936 +312 +16% $15.82 2,312 30 Aug 2021 Direct
transaction FLGT Common Stock Sale $28,409 -312 -13% $91.05 2,000 30 Aug 2021 Direct
transaction FLGT Common Stock Options Exercise $1,813 +312 +16% $5.81* 2,312 30 Aug 2021 Direct
transaction FLGT Common Stock Sale $28,530 -312 -13% $91.44 2,000 30 Aug 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLGT Stock Option (Right to Buy) Options Exercise $0 -312 -25% $0.000000 938 30 Aug 2021 Common Stock 312 $3.92 Direct F1
transaction FLGT Stock Option (Right to Buy) Options Exercise $0 -312 -12% $0.000000 2,188 30 Aug 2021 Common Stock 312 $5.81 Direct F2
transaction FLGT Stock Option (Right to Buy) Options Exercise $0 -312 -8.3% $0.000000 3,438 30 Aug 2021 Common Stock 312 $15.82 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
F2 The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
F3 The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.